We are dedicated to advancing research for neuromuscular disorders by using state-of-the-art Magnetic Resonance (MR) imaging techniques to monitor disease progression and help inform, design, and conduct better clinical trials.
Who We Are
ImagingNMD utilizes advanced magnetic resonance imaging (MRI) and spectroscopy (MRS) as non-invasive biomarkers in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and other neuromuscular diseases. We use extensive data in a multi-site natural history study to monitor and better understand natural disease progression. With our large network of experts around the globe, we engage communities and answer the scientific questions that matter most.
Our Programs & Services
Our services include professional management of all MR-related activities in adherence to the study protocol and local, national and international regulations. Using proprietary processing and analysis techniques, ImagingNMD delivers precise, quantitative MR outcome measures. Services follow all relevant regulatory guidelines for clinical research, and are GCP, GDPR, and CRF Part 11 compliant.
Natural History Studies
We lead the only large-scale natural history study of its kind, dedicated to researching the natural disease progression of Duchenne and Becker muscular dystrophies. As part of this study, you can have a direct impact on the fight for a cure by helping to better understand these diseases and how to monitor them with novel Magnetic Resonance techniques.
Clinical Research Services
We offer a full suite of MR imaging services to pharmaceutical and academic research companies conducting neuromuscular clinical trials, including natural history data-sharing to guide protocol design, trial management and data collection, and the delivery of accurate high-quality imaging data.